Vecuronium is a nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures
Anant Labs manufacture and furnish high quality Vecuronium Bromide impurities for global markets. Our Vecuronium Bromide EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
VECURONIUM BROMIDE50700-72-6NorcuronBromuro de vecuronioORG NC 45Bromure de vecuroniumVecuronii bromidumORG-NC 45MusculaxDTXSID1023736NC-457E4PHP5N1DNSC-759184CHEBI:9940DTXCID003736Bromide, VecuroniumPiperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, bromideVecuronium HydrobromideORG-NC45vAcuroniumVercuroniumvecuronio bromuroNC 45Citrate, VecuroniumMaleate, VecuroniumPhosphate, VecuroniumHydrobromide, VecuroniumRefChem:56989Hydrochloride, VecuroniumORGNC45ORG NC45ORGNC 45NC45M03AC03256-723-9Vecuronium (bromide)MFCD008677621-((2S,3S,5S,10S,13S,16S,17R)-3,17-Diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide1-(3alpha,17beta-Dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium bromide, diacetate[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide(+)-1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromide[(2S,3S,10S,13S,16S,17R)-17-Acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromideC34H57BrN2O4CAS-50700-72-6Vecuronii bromidum [INN-Latin]NCGC00167467-01Bromure de vecuronium [INN-French]Bromuro de vecuronio [INN-Spanish]EINECS 256-723-9UNII-7E4PHP5N1Dvecronium bromideNorcuron (TN)Vecuronium Bromide?Vecuronium bromide CRSVecuronium bromide [USAN:USP:INN:BAN:JAN]5alpha-Androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetateSCHEMBL22250MLS001424317HY-B0118ARVECURONIUM BROMIDE [MI]CHEMBL1200629VECURONIUM BROMIDE [INN]VECURONIUM BROMIDE [JAN]HY-B0118AVecuronium (bromide) (Standard)VECURONIUM BROMIDE [USAN]VEPSYABRBFXYIB-PWXDFCLTSA-MGLXC-03043HMS2052I21HMS3715L15HMS3884C15Pancuronium Bromide EP Impurity DVECURONIUM BROMIDE [VANDF]VECURONIUM BROMIDE [MART.]Vecuronium bromide (JAN/USP/INN)VECURONIUM BROMIDE [USP-RS]VECURONIUM BROMIDE [WHO-DD]Tox21_112471EBC-11164Vecuronium for system suitability CRSAKOS005145904AKOS007930694Tox21_112471_1AC-2000CCG-101147CS-1881FV61481NC00397NSC 759184VECURONIUM BROMIDE [EP IMPURITY]VECURONIUM BROMIDE [ORANGE BOOK]NCGC00167467-03VECURONIUM BROMIDE [EP MONOGRAPH]DS-12625Piperidinium, 1-(3-alpha,17-beta-diacetoxy-2-beta-piperidino-5-alpha-androstan-16-beta-yl)-1-methyl-, bromideSMR000471625VECURONIUM BROMIDE [USP MONOGRAPH]NS00078739S1405V0120D00767EN300-122368F863083Pancuronium bromide impurity, vecuronium bromide -SR-01000763634PANCURONIUM BROMIDE IMPURITY D [EP IMPURITY]SR-01000763634-3Q27108523Vecuronium Bromide; Pancuronium Bromide EP Impurity DZ1541759894Vecuronium Bromide Working Standard (Secondary Reference Standard)Vecuronium bromide, European Pharmacopoeia (EP) Reference StandardPANCURONIUM BROMIDE IMPURITY, VECURONIUM BROMIDE - [USP IMPURITY]Vecuronium bromide, United States Pharmacopeia (USP) Reference Standard1-(3,17-Diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium bromideVecuronium Bromide, Pharmaceutical Secondary Standard; Certified Reference MaterialVecuronium for system suitability, European Pharmacopoeia (EP) Reference Standard(2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane bromide[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetoxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17S)-17-acetyloxy-10,13-dimethyl-16-(1-methyl-3,4,5,6-tetrahydro-2H-pyridin-1-yl)-2-(1-piperidyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate Bromide1-((2S,3S,5S,10S,13S,16S,17R)-3,17-Diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-iumbromide1-[(1R,2S,3aS,3bR,5aS,7S,8S,9aS,9bS,11aS)-1,7-bis(acetyloxy)-9a,11a-dimethyl-8-(piperidin-1-yl)-hexadecahydro-1H-cyclopenta[a]phenanthren-2-yl]-1-methylpiperidin-1-ium bromide1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide1-[3alpha,17beta-bis(acetoxy)-2beta-(1-piperidinyl)-5alpha-androstan-16beta-yl]-1-methylpiperidinium bromide3alpha,17beta-Bis(acetyloxy)-16beta-(1-methylpiperidin-1-ium-1-yl)-2beta-(piperidin-1-yl)-5alpha-androstane bromidePIPERIDINIUM, 1-((2.BETA.,3.ALPHA.,5.ALPHA.,16.BETA.,17.BETA.)-3,17-BIS(ACETYLOXY)-2-(1-PIPERIDINYL)ANDROSTAN-16-YL)-1-METHYL-, BROMIDE